Brain uptake kinetics of nicotine and cotinine after chronic nicotine exposure
Abstract
Blood-brain barrier (BBB) nicotine transfer has been well documented in view of the fact that this alkaloid is a cerebral blood flow marker. However, limited data are available that describe BBB penetration of the major tobacco alkaloids after chronic nicotine exposure. This question needs to be addressed, given long-term nicotine exposure alters both BBB function and morphology. In contrast to nicotine, it has been reported that cotinine (the major nicotine metabolite) does not penetrate the BBB, yet cotinine brain distribution has been well documented after nicotine exposure. Surprisingly, therefore, the literature indirectly suggests that central nervous system cotinine distribution occurs secondarily to nicotine brain metabolism. The aims of the current report are to define BBB transfer of nicotine and cotinine in naive and nicotine-exposed animals. Using an in situ brain perfusion model, we assessed the BBB uptake of [3H]nicotine and [3H]cotinine in naive animals and in animals exposed chronically to S-(-)nicotine (4.5 mg/kg/day) through osmotic minipump infusion. Our data demonstrate that 1) [3H]nicotine BBB uptake is not altered in the in situ perfusion model after chronic nicotine exposure, 2) [3H]cotinine penetrates the BBB, and 3) similar to [3H]nicotine, [3H]cotinine BBB transfer is not altered by chronic nicotine exposure. To our knowledge, this is the first report detailing the uptake of nicotine and cotinine after chronic nicotine exposure and quantifying the rate of BBB penetration by cotinine.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The lack of effect of administered cotinine may be due to insufficient cotinine entry into the brain, with CNS levels too low for efficacy.
“The lack of effect of administered cotinine in the current study may be caused by insufficient cotinine entry into the brain such that the CNS levels were too low for efficacy (Lockman et al., 2005).”
From Nicotinic receptor-mediated reduction in l-DOPA-induced dyskinesias may occur via desensitization (2010) · cites this paper as Lockman et al., 2005
Cites
Role of dopamine in the behavioural actions of nicotine related to addiction
Chiara, G. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00122-9 · Cited by 680 · see citing works
A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes
Messina, E. S., Tyndale, R. F., & Sellers, E. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36947-2 · Cited by 455 · see citing works
Structural and functional aspects of the blood-brain barrier
Begley, D. J., & Brightman, M. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8049-7_2 · Cited by 452 · see citing works
Smokers of Low-Yield Cigarettes Do Not Consume Less Nicotine
Benowttz, N. L., Hall, S. M., Herning, R. I., Jacob, P., Jones, R. T., & Osman, A.-L. (1983) · New England Journal of Medicine · doi:10.1056/nejm198307213090303 · Cited by 442 · see citing works
Absorption and metabolism of nicotine from cigarettes.
ARMITAGE, A. K., Dollery, C. T., George, C. F., Houseman, T. H., Lewis, P. J., & Turner, D. M. (1975) · BMJ · doi:10.1136/bmj.4.5992.313 · Cited by 293 · see citing works
Circadian blood nicotine concentrations during cigarette smoking
Benowitz, N. L., Kuyt, F., & Jacob, P. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.233 · Cited by 292 · see citing works
Cigarette Smoking and Plasma Levels of Nicotine
ISAAC, P. F., & RAND, M. J. (1972) · Nature · doi:10.1038/236308a0 · Cited by 257 · see citing works
Cigarette Smoking: A Dependence on High-Nicotine Boli
Russell, M. A. H., & Feyerabend, C. (1978) · Drug Metabolism Reviews · doi:10.3109/03602537808993776 · Cited by 253 · see citing works
Hawkins, B. T., Abbruscato, T. J., Egleton, R. D., Brown, R. C., Huber, J. D., Campos, C. R., & Davis, T. P. (2004) · Brain Research · doi:10.1016/j.brainres.2004.08.043 · Cited by 227 · see citing works
Self-citationIn Situ Blood–Brain Barrier Transport of Nanoparticles
Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003374.58641.62 · Cited by 182 · see citing works
Self-citationAbbruscato, T. J., Lopez, S. P., Mark, K. S., Hawkins, B. T., & Davis, T. P. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10256 · Cited by 182 · see citing works
Self-citationCigarette smoking decreases cerebral blood flow suggesting increased risk for stroke.
Rogers, R. L., Meyer, J. S., Shaw, T. G., Mortel, K. F., Hardenberg, J. P., & Zaid, R. R. (1983) · PubMed · Cited by 116 · see citing works
Miksys, S. L., Hoffmann, E. B., & Tyndale, R. F. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00281-1 · Cited by 114 · see citing works
A Review of Blood–Brain Barrier Transport Techniques
Smith, Q. R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-419-0:193 · Cited by 113 · see citing works
Ghosheh, O. A., Dwoskin, L. P., Miller, D. K., & Crooks, P. A. (2001) · PubMed · Cited by 111 · see citing works
Ohno, K., Pettigrew, K. D., & Рапопорт, С. И. (1979) · Stroke · doi:10.1161/01.str.10.1.62 · Cited by 111 · see citing works
Todd, M. M., & Weeks, J. B. (1996) · Journal of Neurosurgical Anesthesiology · doi:10.1097/00008506-199610000-00007 · Cited by 109 · see citing works
Effects of chronic oral consumption of nicotine on the rabbit aortic endothelium.
Booyse, F. M., Osikowicz, G., & Quarfoot, A. J. (1981) · PubMed · Cited by 108 · see citing works
Activation and inhibition of the human α7 nicotinic acetylcholine receptor by agonists
Briggs, C. A., & McKenna, D. G. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00110-5 · Cited by 108 · see citing works
Paoletti, P., Fornai, E., Maggiorelli, F., Puntoni, R., Viegi, G., Carrozzi, L., Corlando, A., GUSTAVSSON, G., Säwe, U., & Giuntini, C. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09040643 · Cited by 108 · see citing works
Lockman, P. R., Koziara, J. M., Roder, K. E., Paulson, J. R., Abbruscato, T. J., Mumper, R. J., & Allen, D. D. (2003) · Pharmaceutical Research · doi:10.1023/a:1023492015851 · Cited by 92 · see citing works
Self-citationCrooks, P. A., Li, M., & Dwoskin, L. P. (1997) · PubMed · Cited by 92 · see citing works
Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted
Yamanaka, H., Nakajima, M., Nishimura, K., Yoshida, R., Fukami, T., Katoh, M., & Yokoi, T. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.04.012 · Cited by 85 · see citing works
Abbruscato, T., Lopez, S. P., Roder, K. E., & Paulson, J. R. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.066274 · Cited by 81 · see citing works
Self-citationNicotine metabolism by rat hepatic cytochrome P450s
Nakayama, H., Okuda, H., Nakashima, T., Imaoka, S., & Funae, Y. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90238-r · Cited by 73 · see citing works
The potential role of cotinine in the cognitive and neuroprotective actions of nicotine
Buccafusco, J. J., & Terry, A. V. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00226-1 · Cited by 62 · see citing works
Cerebral Blood Flow During Hemodilution and Hypoxia in Rats
Tomiyama, Y., Brian, J. E., & Todd, M. M. (1999) · Stroke · doi:10.1161/01.str.30.9.1942 · Cited by 62 · see citing works
Halldin, C., Någren, K., Swahn, C., et al. (1992) · International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology · doi:10.1016/0883-2897(92)90173-v · Cited by 61 · see citing works
Allen, D. R., BROWSE, N. L., Rutt, D. L., Butler, L., & Fletcher, C. L. (1988) · Journal of Vascular Surgery · doi:10.1016/0741-5214(88)90387-4 · Cited by 55 · see citing works
Self-citationLinville, D. G., Williams, S., Raszkiewicz, J. L., et al. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39506-6 · Cited by 51 · see citing works
Suzuki, R., Nitsch, C., Fujiwara, K., et al. (1984) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1984.12 · Cited by 50 · see citing works
Hammond, D. K., Bjercke, R. J., Langone, J. J., & Strobel, H. W. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08898-1 · Cited by 50 · see citing works
Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase
Castagnoli, K., Steyn, S. J., Magnin, G., der Schyf, C. J. V., Fourie, I., Khalil, A. A., & Castagnoli, N. (2002) · Neurotoxicity Research · doi:10.1080/10298420290015854 · Cited by 46 · see citing works
Lockman, P. R., der Schyf, C. J. V., Abbruscato, T. J., & Allen, D. D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03162.x · Cited by 41 · see citing works
Self-citationThe Effect of Nicotine on Pulmonary Epithelial Permeability in Man
Minty, B. D., Royston, D., Jones, J. G., et al. (1984) · CHEST Journal · doi:10.1378/chest.86.1.72 · Cited by 37 · see citing works
Nicotine Is More Efficient than Cotinine at Passing the Blood–Brain Barrier in Rats
Riah, O., Courriére, P., Dousset, J.-C., et al. (1998) · Cellular and Molecular Neurobiology · doi:10.1023/a:1022501131709 · Cited by 33 · see citing works
Nicotine Downregulates α2 Isoform of Na,K-ATPase at the Blood-Brain Barrier and Brain in Rats
Wang, L., McComb, J. G., Weiss, M. H., McDonough, A. A., & Zloković, B. V. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1389 · Cited by 33 · see citing works
Metabolism of (−)-(S)-nicotine by guinea pig and rat brain: identification of cotinine
Jacob, P., Ülgen, M., & Gorrod, J. W. (1997) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190975 · Cited by 27 · see citing works
Cigarette smoking decreases cerebral blood flow suggesting increased risk for stroke
Rogers, R. (1983) · JAMA · doi:10.1001/jama.250.20.2796 · Cited by 17 · see citing works
Effects of nicotine on cortical high voltage spindles in rats
Radek, R. J. (1993) · Brain Research · doi:10.1016/0006-8993(93)90133-8 · Cited by 16 · see citing works
Allen, D. R., BROWSE, N. L., Rutt, D. L., et al. (1988) · Journal of Vascular Surgery · doi:10.1067/mva.1988.avs0070139 · Cited by 13 · see citing works
Self-citationTo, M., Wl, J., & Jp, G. (1988) · PubMed · Cited by 12 · see citing works
Schroff, K.-C., Lovich, P., Schmitz, O. J., Aschhoff, S., Richter, E., & Remien, J. (2000) · Toxicology · doi:10.1016/s0300-483x(99)00195-x · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Nicotinic receptor-mediated reduction in l-DOPA-induced dyskinesias may occur via desensitization
Bordia, T., Campos, C., McIntosh, J. M., & Quik, M. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162396 · Cited by 82 · see citing works
- Authors
- Lockman, P. R., McAfee, G., Geldenhuys, W. J., Van der Schyf, C. J., Abbruscato, T. J., & Allen, D. D.
- Affiliations
- Texas Tech University Health Sciences Center (US)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 314
- Issue
- 2
- Pages
- 636-642
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2162830511
- Cited by
- 51
- References
- 43
- Citations by year
- 2026: 2 · 2023: 2 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 2 · 2015: 4 · 2014: 2 · 2013: 5 · 2012: 4
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 046526, R01NS046526)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- nicotine, cotinine, blood-brain barrier, chronic nicotine exposure, tobacco alkaloids, in situ brain perfusion, nicotine metabolism
- MeSH terms
- Animals, Aryl Hydrocarbon Hydroxylases, Blood-Brain Barrier, Brain, Cerebrovascular Circulation, Cotinine, Mixed Function Oxygenases, Nicotine, Perfusion, Rats, Inbred F344, Nicotinic Agonists, Cytochrome P-450 CYP2B1, Rats, Cytochrome P-450 CYP2A6, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review